Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain

BACKGROUND: Tapentadol prolonged release (PR; 100–250 mg twice daily) has been efficacious and well tolerated for managing moderate-to-severe, chronic osteoarthritis hip or knee pain in phase 3 studies with washout of previous analgesic treatment. OBJECTIVE: The objective of this study was to evalua...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Steigerwald, Ilona, Schenk, Michael, Lahne, Uwe, Gebuhr, Peter, Falke, Dietmar, Hoggart, Barbara
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer International Publishing 2013
Pynciau:
Original Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3751342/
https://ncbi.nlm.nih.gov/pubmed/23912473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-013-0102-0
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg